Literature DB >> 11833094

An analysis of 10218 ulcerative colitis cases in China.

Xue-Liang Jiang1, Hui-Fei Cui.   

Abstract

AIM: To analyze the characteristics of ulcerative colitis(UC) in China.
METHODS: From 1981 to 2000, a total of 10218 patients of UC reported in Chinese medical literature and including our cases diagnosed were analyzed according to the diagnostic criteria of Lennard-Jones.
RESULTS: The number of cases increased by 3.08 times over the past 10 years (2506 patients were diagnosed from 1981 to 1990 while 7512 patients were diagnosed from 1991 to 2000). Lesion range were described in 7966 patients, 5592 (70.20%) were proctosigmoiditis or proctitis, 1792(22.50%) left-sided colitis, 582(7.30%) pancolitis. Among the 8122 patients, 2826 (34.8%) had first episode, 4272 (52.6%) had chronic relapse, 869 (10.7%) were of chronic persist type, 154 (1.9%) were of acute fulminant type. The course of the illness were described in 5867 patients, 4427(75.5%) were less than 5 years, 910 (15.5%) between 5 and 10 years,530 (9.1%) more than 10 years. Six hundred and sixteen patients 618 patients(6.1%) had extraintestinal manifestations. The mean age at the diagnosis was 40.7 years( range 6-80 years, and the peak ages 30-49 years). The male to female ratio was 1.09. Among 270 patients diagnosed in our hospital,36 had histories of smoking, there was no negative association between the severity of UC and smoking(P>0.05), 21 smokers were followed up for one year, 15 of them had given up smoking when the disease were diagnosed, and one year later, 7 patients relapsed, another 6 patients continued smoking, and one year later,2 patients relapsed. Among 270 UC patients diagnosed in our hospital, 4 patients(1.48%) from 2 families had familial history of UC. Treatment was mentioned in 6859 patients, only 5-ASA and/or corticosteroid only in 1276 patients(18.6%), only Chinese herbs in 1377 patients(20.1%), combined Chinese and western medicine in 4056 patients(59.1%), surgery was performed in 87 patients(1.3%),other treatments in 63 patients(0.9%).
CONCLUSIONS: In China, number of UC patients increased significantly in the past 10 years. Lesions are commonly located to left side colon. The course is short with rare extraintestinal manifestations. The age of onset is relatively high. Males and females are nearly equally affected. No negative relation was found between smoking and severity of the disease. Familial relatives are rarely involved Traditional Chinese medicine(TCM) is widely used in the treatment of UC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833094      PMCID: PMC4656610          DOI: 10.3748/wjg.v8.i1.158

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin.

Authors:  Hui-Fei Cui; Xue-Liang Jiang
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  A new chronic ulcerative colitis model produced by combined methods in rats.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Current medical therapy for ulcerative colitis.

Authors:  Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

4.  Management of difficult inflammatory bowel disease: where are we now?

Authors:  DS Rampton
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

5.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

6.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

7.  Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998.

Authors:  R Salupere
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

8.  Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines.

Authors:  Huan-Gan Wu; Li-Bin Zhou; Ying-Ying Pan; Cheng Huang; Han-Ping Chen; Zheng Shi; Xue-Gui Hua
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

9.  In vitro production of TNF-alpha,IL-6 and sIL-2R in Chinese patients with ulcerative colitis.

Authors:  Bing Xia; Hai-Jian Guo; JBA Crusius; Chang-Sheng Deng; SGM Meuwissen; AS Pena
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

10.  [Clinical and experimental study on treatment of retention enema for chronic non-specific ulcerative colitis with quick-acting kuijie powder].

Authors:  Q Zhou; J Yu; S Gu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1999-07
View more
  60 in total

1.  Effects of family history on inflammatory bowel disease characteristics in Japanese patients.

Authors:  Erika Kuwahara; Keiko Asakura; Yuji Nishiwaki; Nagamu Inoue; Mamoru Watanabe; Toshifumi Hibi; Toru Takebayashi
Journal:  J Gastroenterol       Date:  2012-03-01       Impact factor: 7.527

2.  Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients.

Authors:  Yan-Cheng Dai; Ya-Li Zhang; Li-Juan Wang; Qian Guo; Kun Yang; Ren-Hao Ye; Zhi-Peng Tang
Journal:  Chin J Integr Med       Date:  2015-10-26       Impact factor: 1.978

Review 3.  Novel pathophysiological concepts of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Haruhiko Ogata
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

4.  Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.

Authors:  Bikramjit Singh; Saurabh Kedia; Gauree Konijeti; Venigalla Pratap Mouli; Rajan Dhingra; Lalit Kurrey; Saurabh Srivastava; Rajesh Pradhan; Govind Makharia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2015-02-07

5.  The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis.

Authors:  Jin Ha Lee; Jae Hee Cheon; Eun Soo Kim; Moon Jae Chung; Wonseok Kang; Duk Hwan Kim; You Jung Ha; Jae Jun Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2009-06-09       Impact factor: 3.199

6.  Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.

Authors:  Dan Li; Bernadette Collins; Fernando S Velayos; Liyan Liu; James D Lewis; James E Allison; Nicole T Flowers; Susan Hutfless; Oren Abramson; Lisa J Herrinton
Journal:  Dig Dis Sci       Date:  2013-10-31       Impact factor: 3.199

7.  Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia.

Authors:  Duminda Subasinghe; N M M Nawarathna; Dharmabandhu Nandadeva Samarasekera
Journal:  J Gastrointest Surg       Date:  2011-06-28       Impact factor: 3.452

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Epidemiology and gene markers of ulcerative colitis in the Chinese.

Authors:  Jun Yun; Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

10.  Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey.

Authors:  Madunil A Niriella; Arjuna P De Silva; Asangi H G K Dayaratne; Madurangi H A D P Ariyasinghe; Metthanandha M N Navarathne; Ranjith S K Peiris; D Nandadeva Samarasekara; Raveendra L Satharasinghe; Sharman Rajindrajith; Anuradha S Dassanayake; A Rajitha Wickramasinghe; H Janaka de Silva
Journal:  BMC Gastroenterol       Date:  2010-03-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.